MRK targets $3B in annual savings by 2027 as it cuts jobs and refocuses investment ahead of Keytruda's 2028 patent cliff.

Merck’s CEO recently shared insights on minimal impacts from EU tariffs and highlighted challenges in Gardasil production.

Mediolanum International Funds Ltd made a hefty cut to its Johnson & Johnson stake, offloading 27.8% of its shares.

Merck plans to cut jobs as part of a $3 billion cost-reduction strategy by 2027, while also lowering its 2025 revenue ...

Earnings from megacaps Meta, Microsoft, Amazon and Apple are due this week and are likely to have a strong influence on ...

Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

Merck paused shipments of Gardasil to China in January. It said the decline was primarily in China, but lower demand in Japan ...

Revenue at SoFi jumps 44%, UnitedHealth slides after restoring financial guidance, and Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys ...

Merck stock fell early Tuesday after Q2 results. The Dow Jones drugmaker plans for job cuts as part of restructuring ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...